SYNAGIS 100 mg/mL


Solution for injection
scheduling status
S4
registration number
50/30.1/0148
What SYNAGIS 100 mg/mL contains
Palivizumab.
other ingredients
Histidine Glycine.
Therapeutic classification
Antiviral monoclonal antibodies (J06BD01 ).
© 2026 SAHPRA. ALL RIGHTS RESERVED